We are please to announce that the QIAI Lab is part of a team that was awarded a U24 grant under NCI’s Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine, which is a new network of sites developing innovative methods to enable co-clinical (animal/human) trials. The grant is entitled “Integrating omics and quantitative imaging data in co-clinical trials to predict treatment response in triple negative breast cancer.” The ePAD technology (http://epad.stanford.edu) developed by the QIAI Lab is central to this grant by bringing quantitative image analysis methods to small animal imaging and unifying quantitative assessment of cancer on images in both animal and human studies to catalyze research in the co-clinical trials paradigm.
